Gene-Targeted eye drops aim to soothe dry eye sufferers
Symptom relief
Recruiting now
This study tests whether licaminlimab eye drops can safely reduce eye discomfort in people with dry eye disease who have a specific gene (TNFR1). About 160 adults will receive either the drug or a placebo (vehicle) for 29 days. The main goal is to see if the drops improve overall…
Phase: PHASE2, PHASE3 • Sponsor: Oculis • Aim: Symptom relief
Last updated May 17, 2026 08:52 UTC